Inventor · disambiguated record
Khalid Shah
Also filed as: SHAH KHALID · SHAH KHALID ALI
36 granted patents·24 pending applications·317 citations·filing 2005–2025
97Inventor score
Files withEXELIXIS INC36MASSACHUSETTS GEN HOSPITAL10ARRAY BIOPHARMA INC5BRIGHAM & WOMENS HOSPITAL INC3WILSON JO ANN2
Top patents by PatentIndex Score
60 records- 0198US10039757B2C-Met modulator pharmaceutical compositionsEXELIXIS INC·Filed 2017·Granted Aug 7, 2018·33 cites·19 claims
- 0298US10034873B2C-met modulator pharmaceutical compositionsEXELIXIS INC·Filed 2017·Granted Jul 31, 2018·33 cites·19 claims
- 0397US11731941B2Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2022·Granted Aug 22, 2023·8 cites·18 claims
- 0497US9724342B2C-met modulator pharmaceutical compositionsWILSON JO ANN·Filed 2011·Granted Aug 8, 2017·43 cites·12 claims
- 0596US11298349B2Processes for preparing quinoline compounds and pharmaceutical compositions containing such compoundsEXELIXIS INC·Filed 2021·Granted Apr 12, 2022·4 cites·3 claims
- 0696US10548888B2C-Met modulator pharmaceutical compositionsEXELIXIS INC·Filed 2018·Granted Feb 4, 2020·9 cites·19 claims
- 0796US10543206B2Processes for preparing quinoline compounds and pharmaceutical compositions containing such compoundsEXELIXIS INC·Filed 2018·Granted Jan 28, 2020·9 cites·20 claims
- 0896US9717720B2Processes for preparing quinoline compounds and pharmaceutical compositions containing such compoundsWILSON JO ANN·Filed 2012·Granted Aug 1, 2017·32 cites·12 claims
- 0995US11724986B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2020·Granted Aug 15, 2023·6 cites·4 claims
- 1095US9234125B2Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using sameWEATHERFORD LAMB·Filed 2013·Granted Jan 12, 2016·8 cites·13 claims
- 1194US10851061B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2019·Granted Dec 1, 2020·8 cites·8 claims
- 1294US9782414B2Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfateARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·22 cites·30 claims
- 1393US10172861B2Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfateARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·15 cites·18 claims
- 1493US9605074B2Multifunctional nanobodies for treating cancerMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Mar 28, 2017·22 cites·3 claims
- 1592US11760726B2Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2021·Granted Sep 19, 2023·2 cites·11 claims
- 1692US11279675B2Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2018·Granted Mar 22, 2022·10 cites·16 claims
- 1792US11123338B2C-met modulator pharmaceutical compositionsEXELIXIS INC·Filed 2019·Granted Sep 21, 2021·2 cites·27 claims
- 1892US10501418B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2015·Granted Dec 10, 2019·12 cites·11 claims
- 1991US12016854B2Liquid dosage forms to treat cancerEXELIXIS INC·Filed 2022·Granted Jun 25, 2024·1 cites·7 claims
- 2091US2025367186A1C-Met Modulator Pharmaceutical CompositionsEXELIXIS INC·Filed 2025·Application pending·0 cites
- 2190US12128039B2Processes for preparing quinoline compounds and pharmaceutical compositions containing such compoundsEXELIXIS INC·Filed 2024·Granted Oct 29, 2024·0 cites·22 claims
- 2290US2025017916A1Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such CompoundsEXELIXIS INC·Filed 2024·Application pending·0 cites
- 2389US2024156804A1C-Met Modulator Pharmaceutical CompositionsEXELIXIS INC·Filed 2023·Application pending·0 cites
- 2488US10813936B2Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-YL)-pyrazolo[1,5-A]pyrimidin-3-YL)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfateARRAY BIOPHARMA INC·Filed 2019·Granted Oct 27, 2020·2 cites·15 claims
- 2587US9862932B2Oncolytic virus therapy for resistant tumorsMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Jan 9, 2018·8 cites·10 claims
- 2686US2025262200A1Processes for preparing quinoline compounds and pharmaceutical compositions containing such compoundsEXELIXIS INC·Filed 2025·Application pending·0 cites
- 2785US8563481B2Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using sameGATLIN LARRY W·Filed 2005·Granted Oct 22, 2013·24 cites·22 claims
- 2884US2022370436A1C-Met Modulator Pharmaceutical CompositionsEXELIXIS INC·Filed 2022·Application pending·0 cites
- 2981US12486233B2Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2023·Granted Dec 2, 2025·0 cites·11 claims
- 3081US11504362B2Liquid dosage forms to treat cancerEXELIXIS INC·Filed 2018·Granted Nov 22, 2022·1 cites·13 claims
- 3181US2022087999A1C-Met Modulator Pharmaceutical CompositionsEXELIXIS INC·Filed 2021·Application pending·0 cites
- 3280US10285993B2Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfateARRAY BIOPHARMA INC·Filed 2017·Granted May 14, 2019·2 cites·9 claims
- 3380US2022023284A1Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such CompoundsEXELIXIS INC·Filed 2021·Application pending·0 cites
- 3480US2022031688A1C-Met Modulator Pharmaceutical CompositionsEXELIXIS INC·Filed 2021·Application pending·0 cites
- 3580US2022175757A1Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such CompoundsEXELIXIS INC·Filed 2022·Application pending·0 cites
- 3680US2021379050A1C-Met Modulator Pharmaceutical CompositionsEXELIXIS INC·Filed 2021·Application pending·0 cites
- 3778US2024307367A1Liquid Dosage Forms to Treat CancerEXELIXIS INC·Filed 2024·Application pending·0 cites
- 3877US2021154185A1Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such CompoundsEXELIXIS INC·Filed 2021·Application pending·0 cites
- 3976US2025134880A1C-met modulator pharmaceutical compositionsEXELIXIS INC·Filed 2025·Application pending·0 cites
- 4075US12227481B2Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2023·Granted Feb 18, 2025·0 cites·9 claims
- 4175US2020108059A1Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such CompoundsEXELIXIS INC·Filed 2019·Application pending·0 cites
- 4272US12017995B2Crystalline forms and salt forms of a kinase inhibitorEXELIXIS INC·Filed 2019·Granted Jun 25, 2024·0 cites·2 claims
- 4370US10676515B2Multimodal trail molecules expressed in T cellsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jun 9, 2020·0 cites·13 claims
- 4470US9428565B2Treatment and bioluminescent visualization using multimodal TRAIL moleculesSHAH KHALID·Filed 2012·Granted Aug 30, 2016·1 cites·13 claims
- 4566US2020197455A1Stem cell delivered oncolytic herpes simplex virus and methods for treating brain tumorsMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 4666US2024300897A1Crystalline forms and salt forms of a kinase inhibitorEXELIXIS INC·Filed 2024·Application pending·0 cites
- 4764US10799505B2Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfateARRAY BIOPHARMA INC·Filed 2015·Granted Oct 13, 2020·0 cites·15 claims
- 4863US2025051284A1Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2022·Application pending·0 cites
- 4963US2025032611A1Gene editing and engineering stem cells for drug deliveryBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Application pending·0 cites
- 5060US10633636B2Oncolytic virus therapy for resistant tumorsMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Apr 28, 2020·0 cites·9 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →